KIMBERLY WALL: Open Payments
NPI 1689310849 · MELROSE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 14 payments from 4 companies in 2025. Trend: 2023 $585 · 2024 $742 · 2025 $555
Food & beverage: $455Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $265 |
| GlaxoSmithKline, LLC. | 8 | $171 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| GENZYME CORPORATION | 1 | $19 |
Products named: TEZSPIRE, NUCALA, DUPIXENT, BREZTRI, TRELEGY ELLIPTA.
Industry payments across MA — which companies pay providers there.
